After long-term follow-up, IBI363 monotherapy demonstrated strong overall survival (OS) with a long tail effect in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results